Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study

被引：0
|
作者：
Busse, William W. [1 ]
Kraft, Monica [2 ]
Domingo, Christian [3 ]
de Mir, Ines [4 ]
Maselli, Diego [5 ]
Xia, Changming [6 ]
Pandit-Abid, Nami [7 ]
Soler, Xavier [8 ]
Jacob-Nara, Juby A. [9 ]
Sacks, Harry [10 ]
Rowe, Paul J. [11 ]
Deniz, Yamo [12 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, UW Allergy Pulm & Crit Care Med, Madison, WI 53706 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Autonoma Barcelona, Pulm Serv, Barcelona, Spain
[4] Hosp Valle De Hebron, Pulm Funct Lab, Barcelona, Spain
[5] UT Hlth, San Antonio, TX USA
[6] Regeneron Pharmaceut Inc, Stat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[7] Sanofi, Global Med Affairs, Bridgewater, MA USA
[8] Regeneron Pharmaceut Inc, Dept Med, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Global Med Affairs Resp Allergy & Gastroenterol, Bridgewater, MA USA
[10] Regeneron Pharmaceut Inc, Immunol & Inflammat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[11] Sanofi, Global Med, Immunol, Bridgewater, MA USA
[12] Regeneron Pharmaceut Inc, Global Clin Dev, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO01-1
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [31] Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study
    Busse, W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
    Papi, A.
    Bourdin, A.
    Watz, H.
    Pavord, I. D.
    Domingo, C.
    Wechsler, M. E.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Mannent, L. P.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] Assessment of Long-Term Maintenance of OCS Reduction and Efficacy in the Dupilumab LIBERTY ASTHMA TRAVERSE Extension Study
    Sher, L.
    Wechsler, M.
    Rabe, K. F.
    Maspero, J. F.
    Daizadeh, N.
    Mao, X.
    Ortiz, B.
    Mannent, L. P.
    Laws, E.
    Ruddy, M. K.
    Pandit-Abid, N.
    Lederer, D. J.
    Hardin, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [34] SUSTAINED IMPROVEMENT IN ASTHMA CONTROL WITH DUPILUMAB TREATMENT IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE TYPE 2 ASTHMA: POST HOC ANALYSIS OF LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Busse, W. W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E. G.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    VALUE IN HEALTH, 2022, 25 (07) : S553 - S554
  • [35] Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Guilbert, Theresa W.
    Tolcachier, Alberto
    Fiocchi, Alessandro G.
    Katelaris, Constance H.
    Phipatanakul, Wanda
    Begin, Philippe
    de Mir, Ines
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 143 - 159
  • [36] Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
    Pavord, Ian
    Busse, William
    Israel, Elliot
    Szefler, Stanley
    Chen, Zhen
    Daizadeh, Nadia
    Lederer, David
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    Khan, Asif
    Zhang, Yi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB4 - AB4
  • [37] Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study
    Maspero, Jorge F.
    Cardona, Guido
    Schonffeldt, Patricia
    Tolcachier, Alberto
    Gonzalez-Diaz, Sandra N.
    Yanez, Anahi
    Galvao, Clovis E.
    Msihid, Jerome
    Gall, Rebecca
    Siddiqui, Shahid
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Djandji, Michel
    JOURNAL OF ASTHMA, 2023, 60 (05) : 981 - 990
  • [38] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
    Miller, Mechelle A.
    Davis, Karla L.
    PEDIATRICS, 2020, 146 : S375 - S375
  • [39] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [40] Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I.
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345